ALFA FinderBSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹47.00
- Market cap
- ₹81.32 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 9.0×Sector 43.0×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Other Announcement
Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.
Shelter Pharma H1 FY27 Results: Net Profit ₹5.2 Cr, Up 15.6% YoY
Shelter Pharma Ltd reported revenue from operations of ₹45.1 Cr (+35.4% YoY) and net profit of ₹5.2 Cr (+15.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.2 Cr · +15.6% YoY
Shelter Pharma Board Meeting Date
Shelter Pharma intimated its Board meeting is scheduled for November 7, 2026, to approve H1 FY27 unaudited results. Trading window remains closed until November 9, 2026.
Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C
Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.
- Value
- ₹0.22 Cr
- From
- First Vet Veterinary Medicines Trading L.L.C
- Execution
- Within the mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹0.1 Cr Order from Genet International
Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.
- Value
- ₹0.10 Cr
- From
- Genet International
- Execution
- Within mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.
Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.
- Value
- ₹3.15 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.
- Execution
- Within mutually agreed timelines as per purchase order schedule
Other board meeting date announcements
All →Ganesha Ecoverse Board Meeting Date
Ganesha Ecoverse Ltd will hold a board meeting on November 14, 2026 to approve unaudited standalone and consolidated half-year results. The trading window stays closed until 48 hours after the results announcement.
Lords Mark Industries Board Meeting Date
Lord's Mark Industries Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Yuvraaj Hygiene Products Board Meeting Date
Yuvraaj Hygiene schedules a 13 November 2026 board meeting to consider unaudited quarter and half-year results. Results are not yet approved; this is advance intimation.
D & H India Board Meeting Date
D & H India Limited has intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated results for the half year ended 30 September 2026. The filing is a prior intimation of the meeting, with no results figures disclosed.
Cemantic Infra-Tech Board Meeting Date
Cemantic Infra-Tech schedules a 13 November 2026 board meeting to consider unaudited September-quarter results and other agenda items. Agenda items are proposed only; nothing decided yet.
Spacenet Enterprises India Board Meeting Date
Spacenet Enterprises schedules a board meeting for November 13, 2026 to consider unaudited half-year results. Trading window stays closed until November 15, 2026.